Cary Street Partners Investment Advisory’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.71K Buy
+128
New +$5K ﹤0.01% 704
2023
Q4
Sell
-5,232
Closed -$147K 678
2023
Q3
$147K Hold
5,232
0.01% 622
2023
Q2
$164K Buy
5,232
+255
+5% +$7.72K 0.01% 558
2023
Q1
$140K Buy
4,977
+2,698
+118% +$73.5K 0.01% 540
2022
Q4
$59.5K Buy
+2,279
New +$54.5K ﹤0.01% 697

Other funds holding ALKS

Cary Street Partners Investment Advisory's ALKS Position: Q2 2026 in Review

Cary Street Partners Investment Advisory opened a new position in Alkermes (ALKS) in Q2 2026: 128 shares worth $6.71K. The stake represents ﹤0.01% of the portfolio and ranks #704 among its holdings. This is a return to the name: Cary Street Partners Investment Advisory previously reported a position in ALKS as recently as Q3 2023.

Cary Street Partners Investment Advisory first reported a position in ALKS in Q4 2022 and has held it in 5 quarters since. The position peaked at $164K in Q2 2023. 169 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Cary Street Partners Investment Advisory held 128 shares of Alkermes worth $6.71K as of Q2 2026.
  • Alkermes was a new Cary Street Partners Investment Advisory position in Q2 2026.
  • Alkermes made up ﹤0.01% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #704 holding.
  • Cary Street Partners Investment Advisory first reported a position in Alkermes in Q4 2022 and has held it in 5 quarters since.
  • Cary Street Partners Investment Advisory's Alkermes position peaked at $164K in Q2 2023.
  • 169 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.